Lbmc Investment Advisors LLC increased its position in shares of Tivity Health Inc (NASDAQ:TVTY) by 296.3% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,477 shares of the company’s stock after purchasing an additional 22,787 shares during the quarter. Tivity Health makes up approximately 0.2% of Lbmc Investment Advisors LLC’s holdings, making the stock its 28th biggest holding. Lbmc Investment Advisors LLC owned approximately 0.08% of Tivity Health worth $1,243,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. UBS Asset Management Americas Inc. acquired a new stake in shares of Tivity Health during the 1st quarter worth approximately $242,000. Alliancebernstein L.P. acquired a new stake in shares of Tivity Health during the 1st quarter worth approximately $1,465,000. Wellington Management Group LLP bought a new position in Tivity Health during the 1st quarter worth approximately $617,000. Teachers Advisors LLC bought a new position in Tivity Health during the 1st quarter worth approximately $2,946,000. Finally, California Public Employees Retirement System bought a new position in Tivity Health during the 1st quarter worth approximately $247,000.
In related news, CAO Glenn Hargreaves sold 5,805 shares of the company’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $45.15, for a total transaction of $262,095.75. Following the completion of the sale, the chief accounting officer now owns 44,448 shares of the company’s stock, valued at $2,006,827.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Mary Flipse sold 7,808 shares of the company’s stock in a transaction dated Monday, September 25th. The stock was sold at an average price of $39.00, for a total transaction of $304,512.00. Following the sale, the insider now directly owns 57,975 shares of the company’s stock, valued at approximately $2,261,025. The disclosure for this sale can be found here. In the last three months, insiders sold 890,837 shares of company stock valued at $32,405,634. 8.42% of the stock is currently owned by company insiders.
Tivity Health Inc (TVTY) traded up $0.10 during trading hours on Monday, hitting $35.95. 701,714 shares of the company’s stock traded hands, compared to its average volume of 498,951. Tivity Health Inc has a 12-month low of $20.60 and a 12-month high of $48.50. The firm has a market capitalization of $1,420.27, a P/E ratio of 21.86, a P/E/G ratio of 2.03 and a beta of 0.18. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.60 and a current ratio of 0.60.
Tivity Health (NASDAQ:TVTY) last released its quarterly earnings data on Thursday, October 26th. The company reported $0.46 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.36 by $0.10. The firm had revenue of $137.70 million for the quarter, compared to the consensus estimate of $137.95 million. Tivity Health had a net margin of 11.45% and a return on equity of 30.23%. The firm’s quarterly revenue was up 10.2% on a year-over-year basis. equities research analysts expect that Tivity Health Inc will post 1.6 earnings per share for the current year.
Several research analysts recently weighed in on TVTY shares. Zacks Investment Research raised shares of Tivity Health from a “hold” rating to a “buy” rating and set a $52.00 price objective on the stock in a research note on Tuesday, October 31st. SunTrust Banks set a $50.00 price target on shares of Tivity Health and gave the company a “buy” rating in a research note on Friday, October 27th. ValuEngine raised shares of Tivity Health from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Jefferies Group reissued a “buy” rating and issued a $46.00 price objective on shares of Tivity Health in a research report on Monday, September 25th. Finally, Cantor Fitzgerald reissued a “buy” rating and issued a $45.00 price objective on shares of Tivity Health in a research report on Monday, November 6th. Two research analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $46.25.
TRADEMARK VIOLATION NOTICE: “Lbmc Investment Advisors LLC Boosts Stake in Tivity Health Inc (NASDAQ:TVTY)” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another site, it was stolen and reposted in violation of US & international copyright law. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2017/12/04/healthways-inc-tvty-holdings-lifted-by-lbmc-investment-advisors-llc.html.
Tivity Health Company Profile
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
Receive News & Ratings for Tivity Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.